Guidance Documents and MAPPs | BsUFA
MaPPs (Manual of Policies and Procedures)
Guidance Documents
- Assessing User Fees Under the Biosimilar User Fee Amendments of 2022
- Labeling for Biosimilar Products (PDF - 143 KB)
- Implementation of the “Deemed to be a License” Provision of the Biologics Price Competition and Innovation Act of 2009 (PDF - 139 KB)
Search "Biosimilar" on the Guidances for Drugs webpage for more Biosimilar guidances.